Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lasmiditan Bioavailability Fed vs Fasted
NCT02233296Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2015
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of lasmiditan in migraine (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Maximum Concentration, Time to Maximum Concentration and 2 more. Started Jan 2015; status: completed.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02233296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233296.